Likewise, HUWE1 genetic inhibition, in combination with chemotherapy, was shown to counteract tumor growth in vivo, suggesting that HUWE1 sustains tumorigenesis and that its deregulation would improve the efficacy of standard of care therapies [169]. The gene discussed is HUWE1; the disease is neoplasm.